Mefenaminsäure Sandoz 125
Mefenaminsäure Sandoz 125 is a medicine authorised by Swissmedic under authorisation number 55390. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 December 1999 and the authorisation is valid without a time limit. ATC code M01AG01 places the medicine in the group Anti-inflammatory and antirheumatic products.
| Authorisation number | 55390 |
|---|---|
| Name | Mefenaminsäure Sandoz 125 |
| Full name | Mefenaminsäure Sandoz 125, Suppositorien |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | M01AG01 |
| First authorisation | 16 December 1999 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Mefenaminsäure Sandoz 125, Suppositorien | B | 16 December 1999 |
| 2 | Mefenaminsäure Sandoz 500, Suppositorien | B | 16 December 1999 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 5 | 10 | Suppositorien | M01AG01 | 07.10.1. | B |
| 7 | 10 | Suppositorien | M01AG01 | 07.10.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Mefenaminsäure Sandoz 125 authorised in Switzerland?
Yes. Mefenaminsäure Sandoz 125 is authorised by Swissmedic under authorisation number 55390, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Mefenaminsäure Sandoz 125 have?
Mefenaminsäure Sandoz 125 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Mefenaminsäure Sandoz 125?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.